journal article·2012-06-13Open access

The effect of cross-linking on the microstructure, mechanical properties and biocompatibility of electrospun polycaprolactone–gelatin/PLGA–gelatin/PLGA–chitosan hybrid composite

Thi-Hiep Nguyen, Byong-Taek Lee

Abstract

In this study, multilayered scaffolds composed of polycaprolactone (PCL)-gelatin/poly(lactic-co-glycolic acid) (PLGA)-gelatin/PLGA-chitosan artificial blood vessels were fabricated using a double-ejection electrospinning system. The mixed fibers from individual materials were observed by scanning electron microscopy. The effects of the cross-linking process on the microstructure, mechanical properties and biocompatibility of the fibers were examined. The tensile stress and liquid strength of the cross-linked artificial blood vessels were 2.3 MPa and 340 mmHg, respectively, and were significantly higher than for the non-cross-linked vessel (2.0 MPa and 120 mmHg). The biocompatibility of the cross-linked artificial blood vessel scaffold was examined using the MTT assay and by evaluating cell attachment and cell proliferation. The cross-linked PCL-gelatin/PLGA-gelatin/PLGA-chitosan artificial blood vessel scaffold displayed excellent flexibility, was able to withstand high pressures and promoted cell growth; thus, this novel material holds great promise for eventual use in artificial blood vessels.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · biodegradable polymer synthesis and properties · Silk-based biomaterials and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (35)

Show source-provided references
1. 10.1046/j.1525-1594.2002.06841.x10.1046/j.1525-1594.2002.06841.x ↗
2. 10.1016/S0142-9612(01)00020-510.1016/S0142-9612(01)00020-5 ↗
3. 10.1016/j.biomaterials.2005.06.01810.1016/j.biomaterials.2005.06.018 ↗
4. 10.3109/1073119960911743110.3109/10731199609117431 ↗
5. 10.1016/S0142-9612(99)00231-810.1016/S0142-9612(99)00231-8 ↗
6. KirklinJ WBarratt-BoyersB G1993 Cardiac Surgery Barratt-BoyersB GKirklinJ W New York Churchill-Livingstone p 861
7. 10.1111/j.1582-4934.2007.00099.x10.1111/j.1582-4934.2007.00099.x ↗
8. 10.1016/j.eurpolymj.2006.04.02110.1016/j.eurpolymj.2006.04.021 ↗
9. 10.1016/j.actbio.2005.06.00610.1016/j.actbio.2005.06.006 ↗
10. 10.1007/BF0321852710.1007/BF03218527 ↗
11. 10.1016/j.biomaterials.2006.11.02410.1016/j.biomaterials.2006.11.024 ↗
12. 10.1016/j.biomaterials.2004.09.05210.1016/j.biomaterials.2004.09.052 ↗
13. 10.1016/j.biomaterials.2006.04.00910.1016/j.biomaterials.2006.04.009 ↗
14. 10.1016/j.biomaterials.2006.09.05110.1016/j.biomaterials.2006.09.051 ↗
15. 10.1002/(ISSN)1552-498110.1002/(ISSN)1552-4981 ↗
16. 10.1016/j.actbio.2007.01.00210.1016/j.actbio.2007.01.002 ↗
17. 10.1016/j.biomaterials.2008.05.01410.1016/j.biomaterials.2008.05.014 ↗
18. 10.1089/ten.2005.11.114910.1089/ten.2005.11.1149 ↗
19. 10.1002/jbm.a.3140810.1002/jbm.a.31408 ↗
20. Wu L · J. Biomed. Mater. Res. A · 2010 · 92 · 56310.1002/jbm.a.32393 ↗
21. 10.1002/masy.v297.110.1002/masy.v297.1 ↗
22. 10.1002/adv.v30.310.1002/adv.v30.3 ↗
23. 10.1021/bm101149r10.1021/bm101149r ↗
24. 10.3740/MRSK.2011.21.2.12510.3740/MRSK.2011.21.2.125 ↗
25. 10.1002/(ISSN)1097-463610.1002/(ISSN)1097-4636 ↗
26. 10.4236/jbise.2010.31214510.4236/jbise.2010.312145 ↗
27. 10.1016/j.msec.2010.04.01210.1016/j.msec.2010.04.012 ↗
28. 10.1007/s10856-010-4048-y10.1007/s10856-010-4048-y ↗
29. 10.1088/1468-6996/12/3/03500210.1088/1468-6996/12/3/035002 ↗
30. 10.1088/0031-9155/52/20/01210.1088/0031-9155/52/20/012 ↗
31. 10.1016/j.ijpharm.2006.04.01110.1016/j.ijpharm.2006.04.011 ↗
32. 10.1021/bm060804s10.1021/bm060804s ↗
33. 10.1107/S002188989801053X10.1107/S002188989801053X ↗
34. 10.1107/S174430910905403710.1107/S1744309109054037 ↗
35. LaredoJXueLHowardP Greisler 2008 Encyclopedia of Biomaterials and Biomedical Engineering 2nd edn. vol. 4 WnekG EBowlinG L London Informa Healthcare p 299710.1201/b18990-290 ↗